MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $2.0M of Moderna, Inc.
Sold$2,017,000
$201.70Price
10,000Shares
What MRNA did after the filing
- The stock from Tue, Dec 27 open, $199.90
- −17.7%
- S&P 500, same days
- +6.3%
Measured over 30 trading days, to the Feb 9 close.
Traded Wed, Dec 21. Filed Fri, Dec 23, 7:30 PM ET, after the close. Returns use the Dec 27 open and the Feb 9 close. Not investment advice.